Femasys Inc.

The momentum for this stock is not very good. Femasys Inc. is not a good value stock. Femasys Inc. is a mediocre stock to choose.
Log in to see more information.

News

Femasys secures distribution partnerships for commercialization of FemaSeed
Femasys secures distribution partnerships for commercialization of FemaSeed

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed  for over $1.3M in Spanish Market
Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed for over $1.3M in Spanish Market

Globe Newswire Company taps Comercial Medico Quirurigca, SA and Durgalab as first EU distributors for its CE-marked women's reproductive healthcare productsATLANTA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Femasys...\n more…

Femasys gets FDA clearance to market FemChec
Femasys gets FDA clearance to market FemChec

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec , an Innovative Diagnostic Solution for Fallopian Tube Check
Femasys Inc. Receives U.S. FDA Clearance to Market FemChec , an Innovative Diagnostic Solution for Fallopian Tube Check

Globe Newswire In addition to 510(k) clearance, FemChec, a contrast generating product, is an integral part of the confirmation test following administration of FemBloc non-surgical permanent birth control...\n more…

Femasys to exhibit at CFAS Annual Meeting
Femasys to exhibit at CFAS Annual Meeting

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Femasys to Exhibit at The Canadian Fertility and Andrology Society's 70th Annual Meeting
Femasys to Exhibit at The Canadian Fertility and Andrology Society's 70th Annual Meeting

Globe Newswire ATLANTA, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...\n more…